Rob Zuiker (born in 1968) studied medicine at the University of Amsterdam and worked as a physician in the Royal Dutch Navy until 2000. He then pursued further education and obtained a master's in Business Administration from Nyenrode University in Breukelen. This led to a position as a medical advisor for Eli Lilly Netherlands. In 2007, Rob joined CHDR as a clinical research physician and has been involved in various projects since. He has been registered as a clinical pharmacologist since 2012 and completed his doctoral degree with a thesis titled "Development and Use of Biomarkers in clinical development of new therapies for chronic airway disease" in 2016. He has been a principal investigator for several studies. Rob currently holds the position of Director of Regulatory & Clinical Services.